Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

SDHA gain-of-function engages inflammatory mitochondrial retrograde signaling via KEAP1-Nrf2.

Burgener AV, Bantug GR, Meyer BJ, Higgins R, Ghosh A, Bignucolo O, Ma EH, Loeliger J, Unterstab G, Geigges M, Steiner R, Enamorado M, Ivanek R, Hunziker D, Schmidt A, Müller-Durovic B, Grählert J, Epple R, Dimeloe S, Lötscher J, Sauder U, Ebnöther M, Burger B, Heijnen I, Martínez-Cano S, Cantoni N, Brücker R, Kahlert CR, Sancho D, Jones RG, Navarini A, Recher M, Hess C.

Nat Immunol. 2019 Oct;20(10):1311-1321. doi: 10.1038/s41590-019-0482-2. Epub 2019 Sep 16.

PMID:
31527833
2.

Use of paediatric early warning scores in intermediate care units.

Lampin ME, Duhamel A, Behal H, Recher M, Leclerc F, Leteurtre S.

Arch Dis Child. 2019 Aug 10. pii: archdischild-2019-317055. doi: 10.1136/archdischild-2019-317055. [Epub ahead of print]

3.

Anemia at Discharge From the PICU: A Bicenter Descriptive Study.

Demaret P, Valla FV, Behal H, Mimouni Y, Baudelet JB, Karam O, Recher M, Duhamel A, Tucci M, Javouhey E, Leteurtre S.

Pediatr Crit Care Med. 2019 Sep;20(9):e400-e409. doi: 10.1097/PCC.0000000000002015.

PMID:
31246740
4.

Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer.

Berner F, Bomze D, Diem S, Ali OH, Fässler M, Ring S, Niederer R, Ackermann CJ, Baumgaertner P, Pikor N, Cruz CG, van de Veen W, Akdis M, Nikolaev S, Läubli H, Zippelius A, Hartmann F, Cheng HW, Hönger G, Recher M, Goldman J, Cozzio A, Früh M, Neefjes J, Driessen C, Ludewig B, Hegazy AN, Jochum W, Speiser DE, Flatz L.

JAMA Oncol. 2019 Jul 1;5(7):1043-1047. doi: 10.1001/jamaoncol.2019.0402. Erratum in: JAMA Oncol. 2019 Jul 1;5(7):1070.

5.

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients.

Fässler M, Diem S, Mangana J, Hasan Ali O, Berner F, Bomze D, Ring S, Niederer R, Del Carmen Gil Cruz C, Pérez Shibayama CI, Krolik M, Siano M, Joerger M, Recher M, Risch L, Güsewell S, Risch M, Speiser DE, Ludewig B, Levesque MP, Dummer R, Flatz L.

J Immunother Cancer. 2019 Feb 20;7(1):50. doi: 10.1186/s40425-019-0523-2.

6.

Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment.

Diem S, Fässler M, Bomze D, Ali OH, Berner F, Niederer R, Hillmann D, Mangana J, Levesque MP, Dummer R, Risch L, Recher M, Risch M, Flatz L.

J Immunother. 2019 Apr;42(3):89-93. doi: 10.1097/CJI.0000000000000255.

PMID:
30768543
7.

Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.

Berger CT, Rebholz-Chaves B, Recher M, Manigold T, Daikeler T.

Ann Rheum Dis. 2019 Jul;78(7):1012-1014. doi: 10.1136/annrheumdis-2018-214704. Epub 2019 Jan 22. No abstract available.

PMID:
30670375
8.

Enhance quality care performance: Determination of the variables for establishing a common database in French paediatric critical care units.

Recher M, Bertrac C, Guillot C, Baudelet JB, Karaca-Altintas Y, Hubert H, Leclerc F, Leteurtre S; French Group for Pediatric Intensive Care and Emergencies (GFRUP).

J Eval Clin Pract. 2018 Aug;24(4):767-771. doi: 10.1111/jep.12984. Epub 2018 Jul 10.

9.

Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.

Quteineh L, Wójtowicz A, Bochud PY, Crettol S, Vandenberghe F, Venetz JP, Manuel O, Golshayan D, Lehmann R, Mueller NJ, Binet I, van Delden C, Steiger J, Mohacsi P, Dufour JF, Soccal PM, Kutalik Z, Marques-Vidal P, Vollenweider P, Recher M, Hess C, Pascual M, Eap CB; Swiss Transplant Cohort Study.

Am J Transplant. 2019 Jan;19(1):238-246. doi: 10.1111/ajt.14971. Epub 2018 Jul 13.

10.

Nano-scale microfluidics to study 3D chemotaxis at the single cell level.

Frick C, Dettinger P, Renkawitz J, Jauch A, Berger CT, Recher M, Schroeder T, Mehling M.

PLoS One. 2018 Jun 7;13(6):e0198330. doi: 10.1371/journal.pone.0198330. eCollection 2018.

11.

Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination.

Recher M, Hirsiger JR, Bigler MB, Iff M, Lemaître B, Scherer K, Häusermann P, Siegrist CA, Berger CT.

NPJ Vaccines. 2018 May 18;3:17. doi: 10.1038/s41541-018-0059-3. eCollection 2018.

12.

Anaphylaxis admissions to pediatric intensive care units in France.

Pouessel G, Chagnon F, Trochu C, Labreuche J, Lejeune S, Recher M, Deschildre A, Leteurtre S; French Group for Pediatric Intensive Care and Emergencies (GFRUP).

Allergy. 2018 Sep;73(9):1902-1905. doi: 10.1111/all.13483. Epub 2018 Jun 19. No abstract available.

PMID:
29787624
13.

Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.

Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Sumnik Z, Sediva A, Slatter M, Arkwright PD, Cant A, Lorenz HM, Giese T, Lougaris V, Plebani A, Price C, Sullivan KE, Moutschen M, Litzman J, Freiberger T, van de Veerdonk FL, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Speckmann C, Ehl S, Leichtner A, Blumberg R, Franke A, Snapper S, Zeissig S, Cunningham-Rundles C, Giulino-Roth L, Elemento O, Dückers G, Niehues T, Fronkova E, Kanderová V, Platt CD, Chou J, Chatila TA, Geha R, McDermott E, Bunn S, Kurzai M, Schulz A, Alsina L, Casals F, Deyà-Martinez A, Hambleton S, Kanegane H, Taskén K, Neth O, Grimbacher B.

J Allergy Clin Immunol. 2018 Dec;142(6):1932-1946. doi: 10.1016/j.jaci.2018.02.055. Epub 2018 May 4.

PMID:
29729943
14.

First-line treatment using high-flow nasal cannula for children with severe bronchiolitis: Applicability and risk factors for failure.

Guillot C, Le Reun C, Behal H, Labreuche J, Recher M, Duhamel A, Leteurtre S.

Arch Pediatr. 2018 Apr;25(3):213-218. doi: 10.1016/j.arcped.2018.01.003. Epub 2018 Mar 15.

PMID:
29551475
15.

Mitochondria-Endoplasmic Reticulum Contact Sites Function as Immunometabolic Hubs that Orchestrate the Rapid Recall Response of Memory CD8+ T Cells.

Bantug GR, Fischer M, Grählert J, Balmer ML, Unterstab G, Develioglu L, Steiner R, Zhang L, Costa ASH, Gubser PM, Burgener AV, Sauder U, Löliger J, Belle R, Dimeloe S, Lötscher J, Jauch A, Recher M, Hönger G, Hall MN, Romero P, Frezza C, Hess C.

Immunity. 2018 Mar 20;48(3):542-555.e6. doi: 10.1016/j.immuni.2018.02.012. Epub 2018 Mar 6.

16.

[18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic.

Imfeld S, Rottenburger C, Schegk E, Aschwanden M, Juengling F, Staub D, Recher M, Kyburz D, Berger CT, Daikeler T.

Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):933-940. doi: 10.1093/ehjci/jex259.

PMID:
29126277
17.

Varicella zoster virus-specific T cell responses in untreated giant cell arteritis: comment on the article by England et al.

Bigler MB, Hirsiger JR, Recher M, Mehling M, Daikeler T, Berger CT.

Arthritis Rheumatol. 2018 Feb;70(2):318-320. doi: 10.1002/art.40363. Epub 2017 Dec 20. No abstract available.

18.

Interleukin-6 flags infection in tocilizumab-treated giant cell arteritis.

Berger CT, Recher M, Daikeler T.

Rheumatology (Oxford). 2018 Jan 1;57(1):196-197. doi: 10.1093/rheumatology/kex336. No abstract available.

PMID:
28968856
19.

Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.

Struja T, Kutz A, Fischli S, Meier C, Mueller B, Recher M, Schuetz P.

BMC Med. 2017 Sep 25;15(1):174. doi: 10.1186/s12916-017-0939-9. Review.

20.

Iron metabolism in patients with Graves' hyperthyroidism.

Fischli S, von Wyl V, Trummler M, Konrad D, Wueest S, Ruefer A, Heering K, Streuli R, Steuer C, Bernasconi L, Recher M, Henzen C.

Clin Endocrinol (Oxf). 2017 Nov;87(5):609-616. doi: 10.1111/cen.13450. Epub 2017 Sep 14.

21.

Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency.

Marquardsen FA, Baldin F, Wunderer F, Al-Herz W, Mikhael R, Lefranc G, Baz Z, Rezaee F, Hanna R, Kfir-Erenfeld S, Stepensky P, Meyer B, Jauch A, Bigler MB, Burgener AV, Higgins R, Navarini AA, Church JA, Chou J, Geha R, Notarangelo LD, Hess C, Berger CT, Bloch DB, Recher M.

J Clin Immunol. 2017 Oct;37(7):707-714. doi: 10.1007/s10875-017-0431-5. Epub 2017 Aug 21.

22.

An in vivo strategy to counteract post-administration anticoagulant activity of azido-Warfarin.

Ursuegui S, Recher M, Krężel W, Wagner A.

Nat Commun. 2017 May 19;8:15242. doi: 10.1038/ncomms15242.

23.

Myeloperoxidase targets oxidative host attacks to Salmonella and prevents collateral tissue damage.

Schürmann N, Forrer P, Casse O, Li J, Felmy B, Burgener AV, Ehrenfeuchter N, Hardt WD, Recher M, Hess C, Tschan-Plessl A, Khanna N, Bumann D.

Nat Microbiol. 2017 Jan 23;2:16268. doi: 10.1038/nmicrobiol.2016.268.

PMID:
28112722
24.

Low immunoglobulin E flags two distinct types of immune dysregulation.

Elkuch M, Greiff V, Berger CT, Bouchenaki M, Daikeler T, Bircher A, Navarini AA, Heijnen I, Recher M.

Clin Exp Immunol. 2017 Mar;187(3):345-352. doi: 10.1111/cei.12885. Epub 2017 Jan 11.

25.

Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis.

Kistner A, Bigler MB, Glatz K, Egli SB, Baldin FS, Marquardsen FA, Mehling M, Rentsch KM, Staub D, Aschwanden M, Recher M, Daikeler T, Berger CT.

Rheumatology (Oxford). 2017 May 1;56(5):829-834. doi: 10.1093/rheumatology/kew469.

PMID:
28064210
26.

Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations.

Nordmann TM, Juengling FD, Recher M, Berger CT, Kalbermatten D, Wicki A, Paasinen-Sohns A, Cathomas G, Tzankov A, Daikeler T.

Blood. 2017 Feb 16;129(7):879-882. doi: 10.1182/blood-2016-09-740217. Epub 2016 Dec 9.

PMID:
27940476
27.

Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.

Navarini AA, Hruz P, Berger CT, Hou TZ, Schwab C, Gabrysch A, Higgins R, Frede N, Padberg Sgier BC, Kämpe O, Burgener AV, Marquardsen F, Baldin F, Bigler M, Kistner A, Jauch A, Bignucolo O, Meyer B, Meienberg F, Mehling M, Jeker LT, Heijnen I, Daikeler TD, Gebbers JO, Grimbacher B, Sansom DM, Jeker R, Hess C, Recher M.

J Allergy Clin Immunol. 2017 Mar;139(3):1043-1046.e5. doi: 10.1016/j.jaci.2016.08.042. Epub 2016 Nov 28. No abstract available.

PMID:
27908448
28.

Allergic Contact Dermatitis.

Kostner L, Anzengruber F, Guillod C, Recher M, Schmid-Grendelmeier P, Navarini AA.

Immunol Allergy Clin North Am. 2017 Feb;37(1):141-152. doi: 10.1016/j.iac.2016.08.014. Review.

PMID:
27886903
29.

CD169+ macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infection.

Shaabani N, Duhan V, Khairnar V, Gassa A, Ferrer-Tur R, Häussinger D, Recher M, Zelinskyy G, Liu J, Dittmer U, Trilling M, Scheu S, Hardt C, Lang PA, Honke N, Lang KS.

Cell Death Dis. 2016 Nov 3;7(11):e2446. doi: 10.1038/cddis.2016.350.

30.

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

Walter JE, Rosen LB, Csomos K, Rosenberg JM, Mathew D, Keszei M, Ujhazi B, Chen K, Lee YN, Tirosh I, Dobbs K, Al-Herz W, Cowan MJ, Puck J, Bleesing JJ, Grimley MS, Malech H, De Ravin SS, Gennery AR, Abraham RS, Joshi AY, Boyce TG, Butte MJ, Nadeau KC, Balboni I, Sullivan KE, Akhter J, Adeli M, El-Feky RA, El-Ghoneimy DH, Dbaibo G, Wakim R, Azzari C, Palma P, Cancrini C, Capuder K, Condino-Neto A, Costa-Carvalho BT, Oliveira JB, Roifman C, Buchbinder D, Kumanovics A, Franco JL, Niehues T, Schuetz C, Kuijpers T, Yee C, Chou J, Masaad MJ, Geha R, Uzel G, Gelman R, Holland SM, Recher M, Utz PJ, Browne SK, Notarangelo LD.

J Clin Invest. 2016 Nov 1;126(11):4389. doi: 10.1172/JCI91162. Epub 2016 Nov 1. No abstract available.

31.

Memory CD8(+) T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal Function.

Balmer ML, Ma EH, Bantug GR, Grählert J, Pfister S, Glatter T, Jauch A, Dimeloe S, Slack E, Dehio P, Krzyzaniak MA, King CG, Burgener AV, Fischer M, Develioglu L, Belle R, Recher M, Bonilla WV, Macpherson AJ, Hapfelmeier S, Jones RG, Hess C.

Immunity. 2016 Jun 21;44(6):1312-24. doi: 10.1016/j.immuni.2016.03.016. Epub 2016 May 17.

32.

A 'Too Negative' ANA Test Predicts Antibody Deficiency.

Recher M, Berger CT, Daikeler T, Hess C, Heijnen IA.

J Clin Immunol. 2016 May;36(4):374-6. doi: 10.1007/s10875-016-0262-9. Epub 2016 Mar 10. No abstract available.

PMID:
26961361
33.

Virus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8(+) T-cell priming and viral control.

Duhan V, Khairnar V, Friedrich SK, Zhou F, Gassa A, Honke N, Shaabani N, Gailus N, Botezatu L, Khandanpour C, Dittmer U, Häussinger D, Recher M, Hardt C, Lang PA, Lang KS.

Sci Rep. 2016 Jan 25;6:19191. doi: 10.1038/srep19191.

34.

Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels.

Bigler MB, Egli SB, Hysek CM, Hoenger G, Schmied L, Baldin FS, Marquardsen FA, Recher M, Liechti ME, Hess C, Berger CT.

PLoS One. 2015 Dec 23;10(12):e0145635. doi: 10.1371/journal.pone.0145635. eCollection 2015.

35.

Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation.

Shaabani N, Khairnar V, Duhan V, Zhou F, Tur RF, Häussinger D, Recher M, Tumanov AV, Hardt C, Pinschewer D, Christen U, Lang PA, Honke N, Lang KS.

J Autoimmun. 2016 Feb;67:82-89. doi: 10.1016/j.jaut.2015.10.004. Epub 2015 Nov 7.

PMID:
26553386
36.

Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN-I responses.

Honke N, Shaabani N, Merches K, Gassa A, Kraft A, Ehrhardt K, Häussinger D, Löhning M, Dittmer U, Hengel H, Recher M, Lang PA, Lang KS.

Eur J Immunol. 2016 Feb;46(2):372-80. doi: 10.1002/eji.201545765. Epub 2015 Nov 17.

37.

N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome.

Volpi S, Santori E, Abernethy K, Mizui M, Dahlberg CI, Recher M, Capuder K, Csizmadia E, Ryan D, Mathew D, Tsokos GC, Snapper S, Westerberg LS, Thrasher AJ, Candotti F, Notarangelo LD.

Blood. 2016 Jan 14;127(2):216-20. doi: 10.1182/blood-2015-05-643817. Epub 2015 Oct 14.

38.

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

Walter JE, Rosen LB, Csomos K, Rosenberg JM, Mathew D, Keszei M, Ujhazi B, Chen K, Lee YN, Tirosh I, Dobbs K, Al-Herz W, Cowan MJ, Puck J, Bleesing JJ, Grimley MS, Malech H, De Ravin SS, Gennery AR, Abraham RS, Joshi AY, Boyce TG, Butte MJ, Nadeau KC, Balboni I, Sullivan KE, Akhter J, Adeli M, El-Feky RA, El-Ghoneimy DH, Dbaibo G, Wakim R, Azzari C, Palma P, Cancrini C, Capuder K, Condino-Neto A, Costa-Carvalho BT, Oliveira JB, Roifman C, Buchbinder D, Kumanovics A, Franco JL, Niehues T, Schuetz C, Kuijpers T, Yee C, Chou J, Masaad MJ, Geha R, Uzel G, Gelman R, Holland SM, Recher M, Utz PJ, Browne SK, Notarangelo LD.

J Clin Invest. 2015 Nov 2;125(11):4135-48. doi: 10.1172/JCI80477. Epub 2015 Oct 12. Erratum in: J Clin Invest. 2016 Nov 1;126(11):4389.

39.

[Cardiac fibroma: A rare cause of sudden child death].

Humez S, Gibier JB, Recher M, Leteurtre S, Leroy X, Devisme L.

Ann Pathol. 2015 Oct;35(5):445-8. doi: 10.1016/j.annpat.2015.05.004. Epub 2015 Sep 12. French.

PMID:
26372501
40.

Virus-Induced Type I Interferon Deteriorates Control of Systemic Pseudomonas Aeruginosa Infection.

Merches K, Khairnar V, Knuschke T, Shaabani N, Honke N, Duhan V, Recher M, Navarini AA, Hardt C, Häussinger D, Tümmler B, Gulbins E, Futerman AH, Hoffmann D, Lang F, Lang PA, Westendorf AM, Lang KS.

Cell Physiol Biochem. 2015;36(6):2379-92. doi: 10.1159/000430200. Epub 2015 Jul 27.

41.

IFN-γ licenses CD11b(+) cells to induce progression of systemic lupus erythematosus.

Shaabani N, Honke N, Dolff S, Görg B, Khairnar V, Merches K, Duhan V, Metzger S, Recher M, Barthuber C, Hardt C, Proksch P, Häussinger D, Witzke O, Lang PA, Lang KS.

J Autoimmun. 2015 Aug;62:11-21. doi: 10.1016/j.jaut.2015.05.007. Epub 2015 Jun 19.

PMID:
26094774
42.

The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years' activity from 2008 to 2014.

Marschall K, Hoernes M, Bitzenhofer-Grüber M, Jandus P, Duppenthaler A, Wuillemin WA, Rischewski J, Boyman O, Heininger U, Hauser T, Steiner U, Posfay-Barbe K, Seebach J, Recher M, Hess C, Helbling A, Reichenbach J; Swiss PID Registry Working Group.

Clin Exp Immunol. 2015 Oct;182(1):45-50. doi: 10.1111/cei.12661. Epub 2015 Jul 29.

43.

Risk factors for pneumocystis pneumonia in giant cell arteritis: a single-centre cohort study.

Berger CT, Greiff V, John S, Koenig KF, Bigler MB, Recher M, Hess C, Daikeler T.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-122-5. Epub 2015 May 26.

PMID:
26016762
44.

Neutralization of colony-stimulating factor 1 receptor prevents sickness behavior syndrome by reprogramming inflammatory monocytes to produce IL-10.

Müller AF, Strauss L, Greter M, Gast H, Recher M, Becher B, Fontana A.

Brain Behav Immun. 2015 Aug;48:78-85. doi: 10.1016/j.bbi.2015.02.027. Epub 2015 Mar 4.

PMID:
25749482
45.

Influenza vaccine response profiles are affected by vaccine preparation and preexisting immunity, but not HIV infection.

Berger CT, Greiff V, Mehling M, Fritz S, Meier MA, Hoenger G, Conen A, Recher M, Battegay M, Reddy ST, Hess C.

Hum Vaccin Immunother. 2015;11(2):391-6. doi: 10.1080/21645515.2015.1008930.

46.

CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production.

Khairnar V, Duhan V, Maney SK, Honke N, Shaabani N, Pandyra AA, Seifert M, Pozdeev V, Xu HC, Sharma P, Baldin F, Marquardsen F, Merches K, Lang E, Kirschning C, Westendorf AM, Häussinger D, Lang F, Dittmer U, Küppers R, Recher M, Hardt C, Scheffrahn I, Beauchemin N, Göthert JR, Singer BB, Lang PA, Lang KS.

Nat Commun. 2015 Feb 18;6:6217. doi: 10.1038/ncomms7217.

47.

Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection.

Xu HC, Huang J, Khairnar V, Duhan V, Pandyra AA, Grusdat M, Shinde P, McIlwain DR, Maney SK, Gommerman J, Löhning M, Ohashi PS, Mak TW, Pieper K, Sic H, Speletas M, Eibel H, Ware CF, Tumanov AV, Kruglov AA, Nedospasov SA, Häussinger D, Recher M, Lang KS, Lang PA.

J Virol. 2015 May;89(9):4748-59. doi: 10.1128/JVI.02976-14. Epub 2015 Feb 11.

48.

Dilated Cardiomyopathy Caused by Wilms Tumor.

Chalavon E, Lampin ME, Lervat C, Leroy X, Bonnevalle M, Recher M, Sudour-Bonnange H.

Pediatr Emerg Care. 2017 Jan;33(1):41-42. doi: 10.1097/PEC.0000000000000338.

PMID:
25626641
49.

Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency.

Wehr C, Gennery AR, Lindemans C, Schulz A, Hoenig M, Marks R, Recher M, Gruhn B, Holbro A, Heijnen I, Meyer D, Grigoleit G, Einsele H, Baumann U, Witte T, Sykora KW, Goldacker S, Regairaz L, Aksoylar S, Ardeniz Ö, Zecca M, Zdziarski P, Meyts I, Matthes-Martin S, Imai K, Kamae C, Fielding A, Seneviratne S, Mahlaoui N, Slatter MA, Güngör T, Arkwright PD, van Montfrans J, Sullivan KE, Grimbacher B, Cant A, Peter HH, Finke J, Gaspar HB, Warnatz K, Rizzi M; Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiency.

J Allergy Clin Immunol. 2015 Apr;135(4):988-97.e6. doi: 10.1016/j.jaci.2014.11.029. Epub 2015 Jan 14.

PMID:
25595268
50.

Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.

Godart F, Houeijeh A, Recher M, Francart C, Polge AS, Richardson M, Cajot MA, Duhamel A.

Arch Cardiovasc Dis. 2015 Jan;108(1):57-63. doi: 10.1016/j.acvd.2014.09.005. Epub 2014 Nov 11.

Supplemental Content

Loading ...
Support Center